Literature DB >> 15878562

Rate-responsive pacing regulated by cardiac haemodynamics.

Gianni Gasparini1, Antonio Curnis, Michele Gulizia, Eraldo Occhetta, Andrea Corrado, Luca Bontempi, Giosuè Mascioli, Giuseppina Maura Francese, Miriam Bortnik, Andrea Magnani, Franco Di Gregorio, Alberto Barbetta, Antonio Raviele.   

Abstract

AIMS: Trans-valvular impedance (TVI) recording has been proposed for the assessment of cardiac haemodynamics, assuming an inverse relationship between TVI and ventricular volume. We checked whether the TVI sensor can drive the rate-responsive function of a cardiac pacemaker following changes in the inotropic regulation of the heart.
METHODS: An external DDD-R pacemaker (Ext Sophos by Medico, Padova, Italy) equipped with the TVI detecting system was tested in 30 patients on the implantation of conventional pacing leads for dual-chamber pacing. Pacing rate regulation was based on the relationship between the stroke volume and the end-diastolic volume, inferred from TVI data. After sensor calibration in basal conditions, beta-adrenergic stimulation was induced by i.v. administration of 2 microg/ml/min isoprenaline (isoproterenol) (IPN). The actual cardiac rate, the TVI waveform, the end-diastolic and systolic TVI in each cardiac cycle and the TVI-indicated rate were stored in memory as a function of time and down-loaded at the end of the session.
RESULTS: All patients with intrinsic atrial activity (28/30) showed a positive chronotropic response to IPN, coupled with a significant increase in end-diastolic TVI and a four-times larger increase in end-systolic TVI. The TVI inotropic index mirrored the sinus rate time-course, with a linear correlation between the two parameters (r(2)>0.7 in 25/28 cases). As a result, the TVI-indicated rate closely reproduced the sinus rate.
CONCLUSIONS: The study confirms the reliability of the haemodynamic information derived from TVI and supports its application in the regulation of rate-responsive pacing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878562     DOI: 10.1016/j.eupc.2005.02.115

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  Key Role of Pacing Site as Determinant Factor of Exercise Testing Performance in Pediatric Patients with Chronic Ventricular Pacing.

Authors:  Michel Cabrera Ortega; Hiram Tápanes Duamy; Dunia B Benítez Ramos
Journal:  Pediatr Cardiol       Date:  2016-12-02       Impact factor: 1.655

2.  Left ventricular mechanical activity detected by impedance recording.

Authors:  Milos Taborsky; Jindrich Kupec; Roman Vopalka; Alberto Barbetta; Franco Di Gregorio
Journal:  Europace       Date:  2010-04       Impact factor: 5.214

3.  Electrical And Hemodynamic Evalution Of Ventricular And Supraventricular Tachycardias With An Implantable Dual-Chamber Pacemaker.

Authors:  Claudio Pandozi; Franco Di Gregorio; Carlo Lavalle; Renato Pietro Ricci; Sabina Ficili; Marco Galeazzi; Maurizio Russo; Angela Pandozi; Furio Colivicchi; Massimo Santini
Journal:  J Atr Fibrillation       Date:  2014-06-30

4.  Usefulness of hemodynamic sensors for physiologic cardiac pacing in heart failure patients.

Authors:  Eraldo Occhetta; Miriam Bortnik; Paolo Marino
Journal:  Cardiol Res Pract       Date:  2011-03-15       Impact factor: 1.866

5.  Hemodynamic Surveillance of Ventricular Pacing Effectiveness with the Transvalvular Impedance Sensor.

Authors:  Valeria Calvi; Giovanni Pizzimenti; Marco Lisi; Giuseppe Doria; Ludovico Vasquez; Francesco Lisi; Salvatore Felis; Donatella Tempio; Alfredo Virgilio; Alberto Barbetta; Franco Di Gregorio
Journal:  Adv Med       Date:  2014-08-04

6.  Impact of acute changes of left ventricular contractility on the transvalvular impedance: validation study by pressure-volume loop analysis in healthy pigs.

Authors:  Vincenzo Lionetti; Simone Lorenzo Romano; Giacomo Bianchi; Fabio Bernini; Anar Dushpanova; Giuseppe Mascia; Martina Nesti; Franco Di Gregorio; Alberto Barbetta; Luigi Padeletti
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.